ABPRO HOLDINGS INC C/WTS 12/11/2029 (TO PUR COM)(ABPWW.US)

longbridge loading
Company Encyclopedia
View More
name
ABPRO HOLDINGS INC C/WTS 12/11/2029 (TO PUR COM)
ABPWW.US
News
View More

Cystinosis market to grow at 5.1% rate from 2025-2034. Established cysteamine treatments dominate, limited new options.

Currently, the cystinosis treatment sector is primarily dominated by traditional cysteamine-based therapies, with minimal access to advanced, curative, or genuinely disease-altering alternatives. Nevertheless, new treatments are starting to revolutionize the field by focusing on...

Unusual Whales·
Unusual Whales·

Merck: teams up with CEPI to make the Ebola vaccine more accessible in low-income countries

Merck has partnered with CEPI to enhance the accessibility of its Ebola vaccine, Ervebo, in low-income countries. The $30 million initiative aims to improve manufacturing and distribution, increasing vaccine yield and shelf life. Collaborating with Hilleman Laboratories, the project will also consider differentiated pricing for public-sector buyers. Key improvements include enabling storage in standard refrigerators, facilitating distribution in remote areas. This partnership is part of a global effort to make epidemic vaccines more sustainable and strengthen outbreak response in vulnerable regions.

marketscreener·
US
MRK
-1.74%
marketscreener·
US
MRK
-1.74%

Global Achromatopsia Market to reach USD 191.22 million by 2032 with 7.58% CAGR growth, highlights genetic advancements.

Dublin - The global market for achromatopsia is projected to witness significant growth, with estimations indicating an increase from USD 121.99 million in 2026 to USD 191.22 million by 2032, representing a compound annual growth rate of 7.58%. This growth is attributed to advancements in genetic characterization, diagnostics, and treatment options within the field of achromatopsia. The market landscape for achromatopsia is outlined in a comprehensive research report available on ResearchAndMarkets.com.

Unusual Whales·
Unusual Whales·

ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges

ProImmune Ltd has announced the Mastering Immunity 2026 symposium, set for April 13-14, 2026, at the Oriental Riverside Hotel in Shanghai. This inaugural event will focus on immunogenicity challenges in drug development, featuring global leaders in biotherapeutics and regulatory authorities. The symposium aims to provide practical guidance for managing immunogenicity risks, which can significantly impact the success of drug programs. Notable speakers include experts from the FDA, Pfizer, and Roche. The event is positioned as essential for those involved in the biopharmaceutical industry in China.

MorningStar·
MorningStar·

Health Rounds: How obesity leads to uncontrolled inflammation discovered

Researchers have discovered the pathway linking obesity to uncontrolled inflammation, which can lead to serious health issues like diabetes and liver disease. The study highlights the role of the NLRP3 protein complex and the enzyme SAMHD1 in this process. Additionally, new research suggests that messenger RNA could be used to improve embryo attachment in the uterus, potentially offering new treatments for infertility. This involves using lipid nanoparticles to deliver genetic material that enhances the endometrium's ability to support embryo implantation.

Reuters·
Reuters·
© 2026 Longbridge｜Disclaimer